Previous studies have suggested that other subsets of high-risk NB with ATM loss through 11q deletion or mutation, or ATRX mutation may also be vulnerable to PARP inhibition through HRR deficiency and fork instability [32,40,41]. This evidence concerns the gene ATM and neuroblastoma.